The short answer is no – THCA flower is not legal for recreational use in Nebraska under the 2026 regulatory revisions, and its medical status remains narrowly confined to a limited list of qualifying conditions. While the 2026 statutes broadened the definition of “cannabis‑derived products” for research and industrial hemp, they did not remove THCA from the controlled‑substance schedule, leaving growers and consumers subject to the same prohibitions that have applied since the 2015 marijuana ban.
What is THCA and why does it matter?
Tetrahydrocannabinolic acid (THCA) is the non‑psychoactive precursor to THC found in raw cannabis buds. When heated, THCA decarboxylates into THC, producing the familiar “high.” Advocates argue THCA offers anti‑inflammatory and neuroprotective benefits without intoxication, prompting a surge of “raw‑flower” products marketed in states where hemp is legal. Nebraska’s 2026 amendments specifically address hemp‑derived cannabinoids, but they preserve the distinction between hemp (≤0.3 % THC) and cannabis that exceeds that threshold, which includes THCA‑rich flower.
2026 Nebraska Cannabis Legislative Changes
Nebraska enacted SB 275 in early 2026, creating a limited medical‑cannabis program for patients with intractable epilepsy, multiple sclerosis, and a few rare disorders. The bill also clarified that hemp‑derived extracts containing less than 0.3 % total THC are permissible for research and industrial use. However, the statute expressly excludes raw cannabis flower that contains any measurable THCA, classifying it as a Schedule I substance under state law.
Legal Analysis of THCA Flower
Nebraska’s controlled‑substance schedule lists “cannabis, any part of the plant” as a prohibited material. Because THCA remains chemically part of the cannabis plant, the 2026 revisions do not create an exemption for raw flower. Courts have interpreted “THC‑like” cannabinoids as falling within the same statutory language, meaning possession, sale, or transport of THCA flower can result in misdemeanor or felony charges, depending on quantity.
Practical Implications for Consumers and Vendors
- Retailers cannot advertise THCA flower without risking enforcement action.
- Patients enrolled in the medical program may access THC‑containing oils prescribed by a qualified physician, but raw THCA material is not part of the approved formulary.
- Researchers may request a waiver from the Nebraska Department of Health and Human Services to study THCA, but such permissions are granted on a case‑by‑case basis and do not establish a commercial market.
Frequently Asked Questions
Is THCA considered a controlled substance in Nebraska?
Yes. Under Nebraska’s Schedule I classification, any part of the cannabis plant that contains THCA is prohibited, regardless of its psychoactive potential.
Can medical patients obtain THCA flower legally?
No. The state’s medical‑cannabis program only permits processed THC or CBD products prescribed by a licensed physician. Raw THCA flower is not included.
Does the 2026 hemp law allow THCA extracts?
Only if the final product contains less than 0.3 % total THC after processing. Pure THCA extracts typically exceed that limit and remain illegal.
What are the penalties for possessing THCA flower?
Possession of up to 1 ounce is generally charged as a misdemeanor with possible fines up to $1,000. Larger quantities may be prosecuted as a felony, carrying harsher fines and potential incarceration.
Are there any future legislative efforts to legalize THCA flower?
Advocacy groups have introduced bills in the 2027 legislative session seeking to carve out an exemption for raw THCA flower used for therapeutic research, but as of the 2026 enactments, no such provisions exist.